| Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study M Zander, S Madsbad, JL Madsen, JJ Holst The Lancet 359 (9309), 824-830, 2002 | 1764 | 2002 |
| Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes M Zander, M Taskiran, MB Toft-Nielsen, S Madsbad, JJ Holst Diabetes Care 24 (4), 720-725, 2001 | 131 | 2001 |
| Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes PV Højberg, M Zander, T Vilsbøll, FK Knop, T Krarup, A Vølund, JJ Holst, ... Diabetologia 51, 632-640, 2008 | 104 | 2008 |
| Four weeks of near‐normalization of blood glucose has no effect on postprandial GLP‐1 and GIP secretion, but augments pancreatic B‐cell responsiveness to a meal in patients … PV Højberg, T Vilsbøll, M Zander, FK Knop, T Krarup, A Vølund, JJ Holst, ... Diabetic medicine 25 (11), 1268-1275, 2008 | 66 | 2008 |
| Video consultations as add-on to standard care among patients with type 2 diabetes not responding to standard regimens: a randomized controlled trial CR Hansen, H Perrild, BG Koefoed, M Zander European journal of endocrinology 176 (6), 727-736, 2017 | 58 | 2017 |
| Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes–a randomized, single-blinded, cross-over pilot study R Faber, M Zander, A Pena, MM Michelsen, ND Mygind, E Prescott Cardiovascular diabetology 14, 1-11, 2015 | 54 | 2015 |
| The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes M Zander, S Madsbad, CF Deacon, JJ Holst Diabetologia 49, 369-374, 2006 | 49 | 2006 |
| Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes M Zander, A Christiansen, S Madsbad, J Juul Holst Diabetes Care 27 (8), 1910-1914, 2004 | 39 | 2004 |
| Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial M Nilsson, N Jensen, M Gejl, ML Bergmann, H Storgaard, M Zander, ... Diabetologia 62, 1948-1958, 2019 | 34 | 2019 |
| Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes K Hermansen, S Vaaler, S Madsbad, M Dalgaard, M Zander, K Begtrup, ... Metabolism-Clinical and Experimental 51 (7), 896-900, 2002 | 34 | 2002 |
| Effects of β-hydroxybutyrate on cognition in patients with type 2 diabetes NJ Jensen, M Nilsson, JS Ingerslev, DA Olsen, M Fenger, M Svart, ... European Journal of Endocrinology 182 (2), 233-242, 2020 | 26 | 2020 |
| Severe hypoglycaemia during treatment with sulphonylureas in patients with type 2 diabetes in the Capital Region of Denmark S Pilemann-Lyberg, B Thorsteinsson, O Snorgaard, M Zander, ... Diabetes Research and Clinical Practice 110 (2), 202-207, 2015 | 17 | 2015 |
| Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction HE Suhrs, KF Raft, K Bové, S Madsbad, JJ Holst, M Zander, E Prescott International Journal of Cardiology 283, 28-34, 2019 | 13 | 2019 |
| Denmark’s comparative position regarding health status, healthcare provision, self-management and social support: Diabetes Attitudes, Wishes and Needs second study (DAWN2) UM Hansen, A Jones, M Zander, I Willaing Scandinavian Journal of Public Health 43 (2), 111-116, 2015 | 11 | 2015 |
| GLP-1 for six weeks reduces weight and improves insulin sensitivity and glycemic control in patients with type 2 diabetes M Zander, S Madsbad, JJ Holst Diabetes 50, A31-A31, 2001 | 11 | 2001 |
| Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study HE Suhrs, M Nilsson, KB Bové, M Zander, E Prescott PLoS One 17 (2), e0263481, 2022 | 9 | 2022 |
| Effect of 4 weeks of near-normalization of blood glucose on beta-cell sensitivity to glucose and GLP-1 in type 2 diabetic patients PV Højberg, M Zander, T Vilsbøll, FK Knop Diabetes 54, A362, 2005 | 8 | 2005 |
| The effect of DPP-4-protected GLP-1 (7–36) on coronary microvascular function in obese adults M Nilsson, KB Bové, E Suhrs, T Hermann, S Madsbad, JJ Holst, ... IJC Heart & Vasculature 22, 139-144, 2019 | 6 | 2019 |
| Stronger meal-related effect of biphasic insulin aspart 30 compared to insulin lispro mix 25 in type 2 diabetes KH Hermansen, S Madsbad, K Koelendorf, M Colombo, M Zander, ... Diabetologia 44, A16-A16, 2001 | 6 | 2001 |
| 4-weeks of near-normalisation of blood glucose has no effect on postprandial GLP-1 secretion but enhances beta cell responsivenes during a meal in patients with type 2 diabetes PV Hojberg, T Vilsboll, M Zander, FK Knop, A Volund, T Krarup, JJ Holst, ... Diabetologia 49, 403-404, 2006 | 4 | 2006 |
